Sciact
  • EN
  • RU

Computational Assessment of Pharmacological, Toxicological, and Electronic Properties of Ephedrine Derivatives Научная публикация

Журнал Eurasian Chemico-Technological Journal
ISSN: 1562-3920
Вых. Данные Год: 2026, Том: 26, Номер: 1, Страницы: 83-91 Страниц : 9 DOI: 10.18321/ectj1685
Авторы Gubenko Maxim 1,2 , Ten Assel 1 , Yergaliyeva Elmira 2 , Dembitsky Valery 3 , Yu Valentina 1
Организации
1 A.B. Bekturov Institute of Chemical Sciences, 106 Sh. Ualikhanov St., Almaty 050010, Kazakhstan
2 Akhmet Baitursynuly Kostanay Regional University, 47 Baytursynov St., Kostanay 110000, Kazakhstan
3 N.D. Zelinsky Institute of Organic Chemistry, 47 Leninsky Prospekt, Moscow 119991, Russia

Реферат: Ephedrine and its derivatives have long been recognized for their therapeutic potential in the treatment of hypotension, asthma, and obesity. However, their use is limited by significant side effects, including cardiovascular risks and toxicity. This study presents a comprehensive computational evaluation of 13 ephedrine derivatives using integrated ADMET analysis, PASS prediction, and quantum-chemical approaches. Pharmacological profiles, toxicity risks, and electronic properties were systematically analyzed to establish structure–activity relationships. Key physicochemical parameters, pharmacokinetic properties, and toxicity risks were analyzed to identify compounds with optimal drug-like characteristics. The results highlight compound 5 as the most promising candidate, demonstrating high drug-likeness (Quantitative Estimate of Drug-likeness, QED = 0.85) and favorable pharmacokinetic properties. Conversely, compounds 3, 11–13 exhibit high toxicity and require structural optimization. PASS predictions indicate diverse biological activities, including spasmolytic and analeptic effects, with compounds 5–7showing significant potential for further development and compound 13 exhibiting antioxidant activity. DFT analysis of ephedrine, cephedrine and key derivatives (compounds 5, 7, 13) revealed an optimal HOMO-LUMO range (ΔE = 4.7–5.0 eV) for compounds with high activity and low toxicity, where derivative 5 exhibits the best balance. This study underscores the importance of rational drug design in optimizing therapeutic efficacy while minimizing adverse effects and environmental risks
Библиографическая ссылка: Gubenko M. , Ten A. , Yergaliyeva E. , Dembitsky V. , Yu V.
Computational Assessment of Pharmacological, Toxicological, and Electronic Properties of Ephedrine Derivatives
Eurasian Chemico-Technological Journal. 2026. V.26. N1. P.83-91. DOI: 10.18321/ectj1685 WOS Scopus OpenAlex
Даты:
Поступила в редакцию: 10 окт. 2025 г.
Принята к публикации: 18 февр. 2026 г.
Опубликована online: 10 апр. 2026 г.
Идентификаторы БД:
≡ Web of science: WOS:001799963800006
≡ Scopus: 2-s2.0-105039100600
≡ OpenAlex: W7154997170
Альметрики: